Guardant Health (GH) Depreciation and Depletion (2017 - 2026)

Guardant Health has reported Depreciation and Depletion for 10 years, with the latest figure at $9.3 million in Q2 2026.

• Quarterly Depreciation and Depletion fell 3.12% year-over-year to $9.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $37.1 million (down 5.84% YoY) and the FY2025 annual result came in at $38.1 million, down 4.99% from the prior year.
• Depreciation and Depletion rose to $9.3 million in Q2 2026 per GH's latest filing, from $9.1 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $10.3 million in Q3 2023 and troughed at $6.7 million in Q1 2022.
• A 5-year average of $9.4 million and a median of $9.6 million in 2023 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2022 and 2025: Depreciation and Depletion soared 82.0% in 2022, then fell 10.89% in 2025.
• Over 5 years, Depreciation and Depletion stood at $9.5 million in 2022, then advanced by 6.32% to $10.1 million in 2023, then slipped by 1.98% to $9.9 million in 2024, then fell by 2.02% to $9.7 million in 2025, then retreated by 4.12% to $9.3 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $9.3 million, $9.1 million, and $9.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.